Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Anglicheau

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2013
Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changesG Canaud, N Kamar, D Anglicheau, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 2, 2010
Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodiesG Canaud, F Bienaimé, L-H Noël, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2008
A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donorsD Anglicheau, A Loupy, C Lefaucheur, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2010
Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodiesR Sberro-Soussan, J Zuber, C Suberbielle-Boissel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 16, 2007
Posttransplant prophylactic intravenous immunoglobulin in kidney transplant patients at high immunological risk: a pilot studyD Anglicheau, A Loupy, C Suberbielle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 5, 2011
Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA)A Loupy, G S Hill, C Suberbielle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 25, 2009
Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodiesA Loupy, C Suberbielle-Boissel, G S Hill, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 31, 2008
Sirolimus may reduce fertility in male renal transplant recipientsJ Zuber, D Anglicheau, C Elie, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 24, 2015
Early Low Urinary CXCL9 and CXCL10 Might Predict Immunological Quiescence in Clinically and Histologically Stable Kidney RecipientsM Rabant, L Amrouche, L Morin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 23, 2009
Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective studyL Zafrani, L Truffaut, H Kreis, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2013
Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changesG Canaud, N Kamar, D Anglicheau, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 2, 2010
Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodiesG Canaud, F Bienaimé, L-H Noël, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2008
A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donorsD Anglicheau, A Loupy, C Lefaucheur, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2010
Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodiesR Sberro-Soussan, J Zuber, C Suberbielle-Boissel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 16, 2007
Posttransplant prophylactic intravenous immunoglobulin in kidney transplant patients at high immunological risk: a pilot studyD Anglicheau, A Loupy, C Suberbielle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 5, 2011
Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA)A Loupy, G S Hill, C Suberbielle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 25, 2009
Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodiesA Loupy, C Suberbielle-Boissel, G S Hill, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 31, 2008
Sirolimus may reduce fertility in male renal transplant recipientsJ Zuber, D Anglicheau, C Elie, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 24, 2015
Early Low Urinary CXCL9 and CXCL10 Might Predict Immunological Quiescence in Clinically and Histologically Stable Kidney RecipientsM Rabant, L Amrouche, L Morin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 23, 2009
Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective studyL Zafrani, L Truffaut, H Kreis, et al.
Pageof 4